Is 3D Systems Corporation (NYSE:DDD) a buy in 2026?
Hold. 3D Systems Corporation is a wait-and-watch at today's price, not a fresh buy.
A pioneer turned penny stock with real healthcare assets, but cash burn and a brutal industrial cycle keep this a wait-and-watch.
Where DDD is headed
3D Systems in 2028 is a smaller, more focused company than the one that IPO'd the additive manufacturing dream in 2011. The industrial polymer business that built the brand is now a slow-grower fighting Stratasys, HP, and a wave of cheaper Chinese systems on price. The healthcare segment, personalized medical devices, dental aligners, regenerative medicine partnerships with United Therapeutics on bioprinted lungs, is where the equity story actually lives. By late 2027, I expect healthcare to be roughly 50% of revenue, up from the low-40s today, at materially higher gross margins than the industrial side.
Read the full Compass Direction on DDD
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $3.19).
See the full DDD analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is 3D Systems Corporation (NYSE:DDD) a buy in 2026?
Hold. 3D Systems Corporation is a wait-and-watch at today's price, not a fresh buy. A pioneer turned penny stock with real healthcare assets, but cash burn and a brutal industrial cycle keep this a wait-and-watch.
What is DDD's Compass Score?
3D Systems Corporation scores 77/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for DDD?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the DDD page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.